The ameliorative effects of berberine (300 mg/kg) on ECM accumulation may be due to decreased TGF-β1 and ICAM-1 resulting from inhibition of the NF-κB pathway, as shown in a rat model of DN (Liu et al., 2010a). Here, ICAM1 is linked to liver dysplastic nodule.